Westover Capital Advisors, LLC Gilead Sciences, Inc. Transaction History

Westover Capital Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$73.27 - $83.09 $1,392 - $1,578	19 Added 0.51%	3,779 $306,000
Q2 2023 Aug 11, 2023	BUY	$76.01 - $86.7 $285,797 - $325,992	3,760 New	3,760 $289,000
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $436,148 - $496,970	-7,699 Closed	0 $0
Q3 2020 Nov 19, 2020	SELL	$62.1 - $78.08 $108,054 - $135,859	-1,740 Reduced 18.43%	7,699 $486,000
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $438,814 - $509,544	6,066 Added 179.84%	9,439 $726,000
Q1 2020 May 18, 2020	BUY	$62.63 - $80.22 $211,250 - $270,582	3,373 New	3,373 $252,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Westover Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Westover Capital Advisors, LLC with notifications on news.